Newron Pharmaceuticals (Switzerland) Price on December 2, 2024
| NWRN Stock | CHF 8.49 0.49 6.13% |
If you're considering investing in Newron Stock, it is important to understand the factors that can impact its price. As of today, the current price of Newron Pharmaceuticals stands at 8.49, as last reported on the 26th of December, with the highest price reaching 8.49 and the lowest price hitting 8.00 during the day. Newron Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Newron Pharmaceuticals has Sharpe Ratio of 0.0548, which conveys that the firm had a 0.0548% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Newron Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Newron Pharmaceuticals' Mean Deviation of 2.48, risk adjusted performance of 0.0511, and Downside Deviation of 2.77 to check out if our risk estimates are consistent with your expectations.
Newron Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Newron |
Sharpe Ratio = 0.0548
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NWRN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.01 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Newron Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Newron Pharmaceuticals by adding it to a well-diversified portfolio.
Newron Pharmaceuticals Valuation on December 2, 2024
It is possible to determine the worth of Newron Pharmaceuticals on a given historical date. On December 2, 2024 Newron was worth 7.31 at the beginning of the trading date compared to the closed value of 7.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Newron Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Newron Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Newron Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Newron Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 7.50 | 7.86 | 7.50 | 7.74 | 41,436 | |
12/02/2024 | 7.31 | 7.83 | 7.31 | 7.83 | 49,526 |
| 7.70 | 7.84 | 7.60 | 7.60 | 62,694 |
| Backtest Newron Pharmaceuticals | | | Newron Pharmaceuticals History | | | Newron Pharmaceuticals Valuation | Previous | Next |
Newron Pharmaceuticals Trading Date Momentum on December 2, 2024
| On December 03 2024 Newron Pharmaceuticals SpA was traded for 7.60 at the closing time. The highest price during the trading period was 7.84 and the lowest recorded bid was listed for 7.60 . The volume for the day was 62.7 K. This history from December 3, 2024 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 2.94% . The trading delta at closing time to the current price is 3.45% . |
Newron Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Newron Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Newron Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Newron financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Newron Pharmaceuticals Stock history
Newron Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Newron is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Newron Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Newron Pharmaceuticals stock prices may prove useful in developing a viable investing in Newron Pharmaceuticals
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system in Italy and internationally. The company was founded in 1998 and is headquartered in Bresso, Italy. NEWRON PHARMA operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 24 people.
Newron Pharmaceuticals Stock Technical Analysis
Newron Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Newron Pharmaceuticals Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Newron Pharmaceuticals SpA cannot be verified against its exchange. Please verify the symbol is currently traded on SIX Swiss Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Newron Pharmaceuticals December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Newron Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Newron Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Newron Pharmaceuticals stock market strength indicators, traders can identify Newron Pharmaceuticals SpA entry and exit signals to maximize returns
Newron Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Newron Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Newron Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Newron to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0511 | |||
| Jensen Alpha | 0.1993 | |||
| Total Risk Alpha | 0.0314 | |||
| Sortino Ratio | 0.0606 | |||
| Treynor Ratio | 2.08 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Newron Stock Analysis
When running Newron Pharmaceuticals' price analysis, check to measure Newron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Newron Pharmaceuticals is operating at the current time. Most of Newron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Newron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Newron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Newron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.